Trial Profile
European Phase-IIb Clinical Trial Evaluating Efficacy of Low Dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes DIABIL-2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2023
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms DIABIL-2
- 11 Aug 2023 Status changed from active, no longer recruiting to completed.
- 03 Aug 2021 This trial has been completed in Netherland, according to European Clinical Trials Database record.
- 31 Jul 2021 This trial has been completed in Germany, according to European Clinical Trials Database record.